RNVU1-31

Across TCGA pan-cancer cohorts, RNVU1-31 RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated RNVU1-31 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher RNVU1-31 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNVU1-31 expression acts as an unfavorable survival marker, although some lineages such as CESC and DLBC show a favorable association.

ACC, MESO, and KICH are the cancer types where RNVU1-31 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Quartile	All	0.157	0.563	<.001	49	view →
MESO	OS	Tertile	All	0.262	0.464	.006	32	view →
KICH	DFS	Tertile	All	0.475	0.910	.003	30	view →
ESCA	OS	Median	III,IV	0.439	0.693	.008	30	view →
KIRC	DFS	Median	All	0.498	0.686	.009	24	view →
CESC	DFS	Tertile	All	0.889	0.780	.016	20	view →
KIRP	OS	Tertile	IV	0.040	0.471	.015	18	view →
PRAD	DFS	Quartile	All	0.641	0.840	.021	12	view →
SKCM	OS	Tertile	IV	0.279	0.670	.035	9	view →
COAD	DFS	Quartile	IV	0.285	0.505	.024	9	view →
LIHC	DFS	Quartile	III,IV	0.239	0.469	.010	8	view →
READ	DFS	Tertile	IV	0.304	0.736	.020	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

RNVU1-31–ACC (DFS)

Open the ACC breakdown →